NASDAQ: VANI
Vivani Medical Inc Stock Forecast, Predictions & Price Target

Analyst price target for VANI

Based on 1 analyst offering 12 month price targets for Vivani Medical Inc

Min Forecast
$3.00+132.56%
Avg Forecast
$3.00+132.56%
Max Forecast
$3.00+132.56%

Should I buy or sell VANI stock?

Based on 1 analyst offering ratings for Vivani Medical Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although VANI's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates VANI as a "Sell". Stocks with a Zen Rating of Sell have trailed the market by -4.50%. Learn More

Be the first to know when Wall Street analysts revise their VANI stock forecasts and price targets.

VANI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-11-07

1 of 1

Forecast return on equity

Is VANI forecast to generate an efficient return?

Company
N/A
Industry
12,676.54%
Market
291.52%

Forecast return on assets

Is VANI forecast to generate an efficient return on assets?

Company
N/A
Industry
5,174.01%

VANI earnings per share forecast

What is VANI's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.41
Avg 2 year Forecast
-$0.41

VANI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VANI$1.29$3.00+132.56%Buy
CLSD$1.01$5.75+469.31%Strong Buy
BLUE$0.39$2.90+639.80%Buy
AGEN$3.27$12.50+282.26%Buy
OVID$1.09$3.05+179.82%Strong Buy

Vivani Medical Stock Forecast FAQ

Is Vivani Medical Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: VANI) stock is to Buy VANI stock.

Out of 1 analyst, 0 (0%) are recommending VANI as a Strong Buy, 1 (100%) are recommending VANI as a Buy, 0 (0%) are recommending VANI as a Hold, 0 (0%) are recommending VANI as a Sell, and 0 (0%) are recommending VANI as a Strong Sell.

If you're new to stock investing, here's how to buy Vivani Medical stock.

What is VANI's earnings growth forecast for 2024-2025?

(NASDAQ: VANI) Vivani Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.47%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.84%.

Vivani Medical's earnings in 2024 is -$23,462,000.On average, 1 Wall Street analyst forecast VANI's earnings for 2024 to be -$24,286,222, with the lowest VANI earnings forecast at -$24,286,222, and the highest VANI earnings forecast at -$24,286,222.

In 2025, VANI is forecast to generate -$24,286,222 in earnings, with the lowest earnings forecast at -$24,286,222 and the highest earnings forecast at -$24,286,222.

What is VANI's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: VANI) forecast ROE is N/A, which is considered weak.

What is VANI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year VANI price target, the average VANI price target is $3.00, with the highest VANI stock price forecast at $3.00 and the lowest VANI stock price forecast at $3.00.

The Wall Street analyst predicted that Vivani Medical's share price could reach $3.00 by Nov 7, 2025. The average Vivani Medical stock price prediction forecasts a potential upside of 132.56% from the current VANI share price of $1.29.

What is VANI's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: VANI) Vivani Medical's current Earnings Per Share (EPS) is -$0.44. On average, analysts forecast that VANI's EPS will be -$0.41 for 2024, with the lowest EPS forecast at -$0.41, and the highest EPS forecast at -$0.41. In 2025, VANI's EPS is forecast to hit -$0.41 (min: -$0.41, max: -$0.41).

What is VANI's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: VANI) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 5,174.01%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.